Form 4: Third Harmonic Bio Chief Medical Officer Executes Stock Option and Sells Shares

Third Harmonic Bio's Chief Medical Officer, Edward R. Conner, exercised stock options and sold the resulting shares on November 8, 2024, according to a recent SEC filing.

Summary

• Edward R. Conner, Chief Medical Officer of Third Harmonic Bio, executed a stock option grant to acquire 2,117 shares of common stock at a price of $4.20 per share on November 8, 2024.
• Concurrently, Mr. Conner sold 2,117 shares of common stock at a price of $15.00 per share.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 27, 2024.
• Following these transactions, Mr. Conner directly owns 368,918 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing insider transactions, which is neither positive nor negative in itself. The transactions are expected due to the pre-arranged trading plan.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• The use of a Rule 10b5-1 trading plan is a common practice among corporate executives to avoid accusations of insider trading.
• The vesting schedule of the options is typical for employee stock option grants in the biotech industry.
• The sale of shares after exercising options is a standard practice for executives to realize gains from their equity compensation.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are part of a pre-arranged trading plan and do not indicate a change in the company's fundamentals.

Key Dates

Keywords

stock options, insider trading, SEC Form 4, Rule 10b5-1, equity securities, Third Harmonic Bio, Chief Medical Officer